Following the launch of Round 2 of the IMIV MRI Pump-Priming Research Scheme, the window for applications for innovative MRI research projects has re-opened.
The aim of the scheme is to support projects that will lead to competitive external funding applications for MR imaging studies. Applications are therefore required to demonstrate a clear plan for progressing preliminary studies to grant applications and larger studies.
- All projects must have a Bournemouth University researcher as lead or co-lead applicant (see application form).
- The IMIV MRI Pump-Priming Scheme Round 2 has a rolling 3-month window for applications, rather than a single deadline, and up to 200 hours of scanning time to be awarded in total in 2021/22.
- There is no limit on the number of scanning hours that can be applied for, but projects applying for an award of more than 20 hours may be subject to external peer review. Awards will not cover any additional expenses related to scanning, or other aspects of the project.
- Projects must be deliverable within 12 months, including ethical approvals. Projects with ethical approvals already in place will be prioritised.
The second window for applications is now open, and closes on Friday 22nd April 2022. Subject to availability, there will be further application windows during the year.
To receive the application form, please email imiv@bournemouth.ac.uk.
IMIV MRI Pump-Priming Research Scheme










Join the 17th Annual Postgraduate Research Conference – Wednesday 3 December 2025
BU Festival of Social Sciences invite at RNLI
MaGPIE Presents at UK Parliament: From Mass Graves to Courtroom
Festival of Social Science: Introducing drowning prevention in Bangladesh
BU PhD student attending HIV conference on scholarship
ECR Funding Open Call: Research Culture & Community Grant – Apply Now
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease